A randomized controlled trial in Germany found that dronabinol, a cannabis-derived THC medication, significantly decreased nightmares in patients with post-traumatic stress disorder in a double-blind study published in Nature Medicine.
Researchers have developed an artificial intelligence foundation model that analyzes routine polysomnography data to identify patients' long-term health risks, with high-risk patients showing twice the mortality risk over five years compared to low-risk patients. The study, published in Nature Communications, demonstrates that sleep studies contain far more predictive health information than currently utilized by clinicians.
Recent studies show that night owls and shift workers face elevated risks of heart attacks, strokes, and other cardiovascular problems, with healthcare workers reporting chronic health issues and premature deaths among colleagues working overnight schedules.
